venBio Global Strategic Fund III L.P. 13D and 13G filings for Artiva Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:56 pm Sale |
2024-09-30 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,519,971 6.300% |
-298,624 (-16.42%) |
Filing |
| 2024-08-01 7:00 pm Purchase |
2024-07-22 | 13G | Artiva Biotherapeutics, Inc. ARTV |
venBio Global Strategic Fund III L.P. | 1,818,595 7.800% |
1,818,595 (New Position) |
Filing |